International Severe Asthma Registry — Hong Kong
International Severe Asthma Registry
Chinese University of Hong Kong · NCT07524543
This registry collects health and treatment information from adults with severe asthma in Hong Kong to see how current care and medications affect outcomes over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT07524543 on ClinicalTrials.gov |
What this trial studies
The Hong Kong arm of the International Severe Asthma Registry will retrospectively and prospectively collect standardized clinical data from adults with severe asthma at participating centers. Data collection uses an annualized core dataset with optional enhanced variables, consistent coding, and standardized response options to ensure comparability. All clinical information will be anonymized before being pooled for analysis. The dataset will be used to track treatment responses, exacerbations, and health service use to inform future research and care improvements.
Who should consider this trial
Good fit: Adults aged 18 or older in Hong Kong with physician-diagnosed severe asthma who can provide written informed consent.
Not a fit: People under 18, those who cannot provide written consent, or patients without severe asthma are not eligible and are unlikely to gain direct benefit from this registry.
Why it matters
Potential benefit: If successful, the registry could help clinicians better understand severe asthma patterns and improve treatment decisions and clinical guidelines for patients.
How similar studies have performed: International severe asthma registries, including ISAR, have previously generated useful real-world evidence that has informed treatment patterns and guideline development.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient with severe asthma with age 18 or over will be recruited. Exclusion Criteria: Patients who cannot provide written consent
Where this trial is running
Hong Kong
- The Chinese University of Hong Kong — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Study coordinator: Wai San Fanny Ko, MD
- Email: fannyko@cuhk.edu.hk
- Phone: +852 35053133
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Asthma